RVL Pharmaceuticals Plc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RVLPQ and buy or sell other stocks, ETFs, and their options commission-free!About RVLPQ
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, Lorzone, and M-72.
CEOBrian A. Markison, CPA
CEOBrian A. Markison, CPA
Employees125
Employees125
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1986
Founded1986
Employees125
Employees125
RVLPQ Key Statistics
Market cap0.00
Market cap0.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume593.33
Average volume593.33
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume124.65K
Volume124.65K
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
RVL Pharmaceuticals Plc(RVLPQ) stock is priced at $0.00, giving the company a market capitalization of 0.
On 2026-07-15, RVL Pharmaceuticals Plc(RVLPQ) stock opened at —, reached a high of —, and a low of —.
RVL Pharmaceuticals Plc(RVLPQ) shares are trading with a volume of 124.65K, against a daily average of 593.33.
In the last year, RVL Pharmaceuticals Plc(RVLPQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, RVL Pharmaceuticals Plc(RVLPQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own RVLPQ. This list is generated using Robinhood data, and it’s not a recommendation.